Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature

Psoriasis and type 1 diabetes mellitus (T1DM) are chronic autoimmune diseases sharing common immunological pathways, particularly the involvement of interleukin 17 (IL-17), driving Th17-mediated inflammation. This review explores the overlap between psoriasis, obesity, T1DM, and necrobiosis lipoidic...

Full description

Saved in:
Bibliographic Details
Main Authors: Angelika Bielach-Bazyluk, Filip Bossowski, Magdalena Skorupska, Hanna Mysliwiec, Artur Tadeusz Bossowski, Iwona Flisiak
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/8/610
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850156073574465536
author Angelika Bielach-Bazyluk
Filip Bossowski
Magdalena Skorupska
Hanna Mysliwiec
Artur Tadeusz Bossowski
Iwona Flisiak
author_facet Angelika Bielach-Bazyluk
Filip Bossowski
Magdalena Skorupska
Hanna Mysliwiec
Artur Tadeusz Bossowski
Iwona Flisiak
author_sort Angelika Bielach-Bazyluk
collection DOAJ
description Psoriasis and type 1 diabetes mellitus (T1DM) are chronic autoimmune diseases sharing common immunological pathways, particularly the involvement of interleukin 17 (IL-17), driving Th17-mediated inflammation. This review explores the overlap between psoriasis, obesity, T1DM, and necrobiosis lipoidica (NL), a skin condition associated with diabetes. Obesity exacerbates inflammation through immune cell activation in adipose tissue and the release of proinflammatory adipokines, such as leptin, resistin, and IL-18, which enhance autoimmune responses and insulin resistance. Leptin promotes the differentiation of Th1 and Th17 cells, which are central to autoimmune responses in both psoriasis and T1DM. The coexistence of psoriasis, T1DM, and insulin resistance further complicates metabolic control, increasing the risk of complications like diabetic nephropathy and cardiovascular disease. Biologic treatments targeting IL-17A and IL-17F offer promising therapeutic options for managing both skin and metabolic symptoms. The early identification and management of metabolic risk factors, along with personalized interventions, are essential to improve clinical outcomes in patients with psoriasis and T1DM, particularly in obese individuals. This case report and review highlight the complex interplay of these conditions and emphasize the need for integrated treatment strategies.
format Article
id doaj-art-f8d8d2aaeefa45dfbb7d277fd600f048
institution OA Journals
issn 2073-4409
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-f8d8d2aaeefa45dfbb7d277fd600f0482025-08-20T02:24:42ZengMDPI AGCells2073-44092025-04-0114861010.3390/cells14080610Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of LiteratureAngelika Bielach-Bazyluk0Filip Bossowski1Magdalena Skorupska2Hanna Mysliwiec3Artur Tadeusz Bossowski4Iwona Flisiak5Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, PolandStudents’ Scientific Society at the Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, PolandStudents’ Scientific Society at the Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, PolandDepartment of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, PolandDepartment of Pediatrics, Endocrinology, Diabetology with Cardiology Divisions, Medical University of Bialystok, 15-274 Bialystok, PolandDepartment of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, PolandPsoriasis and type 1 diabetes mellitus (T1DM) are chronic autoimmune diseases sharing common immunological pathways, particularly the involvement of interleukin 17 (IL-17), driving Th17-mediated inflammation. This review explores the overlap between psoriasis, obesity, T1DM, and necrobiosis lipoidica (NL), a skin condition associated with diabetes. Obesity exacerbates inflammation through immune cell activation in adipose tissue and the release of proinflammatory adipokines, such as leptin, resistin, and IL-18, which enhance autoimmune responses and insulin resistance. Leptin promotes the differentiation of Th1 and Th17 cells, which are central to autoimmune responses in both psoriasis and T1DM. The coexistence of psoriasis, T1DM, and insulin resistance further complicates metabolic control, increasing the risk of complications like diabetic nephropathy and cardiovascular disease. Biologic treatments targeting IL-17A and IL-17F offer promising therapeutic options for managing both skin and metabolic symptoms. The early identification and management of metabolic risk factors, along with personalized interventions, are essential to improve clinical outcomes in patients with psoriasis and T1DM, particularly in obese individuals. This case report and review highlight the complex interplay of these conditions and emphasize the need for integrated treatment strategies.https://www.mdpi.com/2073-4409/14/8/610psoriasistype 1 diabetesobesitymetabolic syndromeIL-17double diabetes
spellingShingle Angelika Bielach-Bazyluk
Filip Bossowski
Magdalena Skorupska
Hanna Mysliwiec
Artur Tadeusz Bossowski
Iwona Flisiak
Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
Cells
psoriasis
type 1 diabetes
obesity
metabolic syndrome
IL-17
double diabetes
title Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
title_full Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
title_fullStr Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
title_full_unstemmed Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
title_short Psoriasis in Obese Adolescents with Diabetes—From Common Molecular Background to Vicious Circle of Metabolic Syndrome—Case Report and Review of Literature
title_sort psoriasis in obese adolescents with diabetes from common molecular background to vicious circle of metabolic syndrome case report and review of literature
topic psoriasis
type 1 diabetes
obesity
metabolic syndrome
IL-17
double diabetes
url https://www.mdpi.com/2073-4409/14/8/610
work_keys_str_mv AT angelikabielachbazyluk psoriasisinobeseadolescentswithdiabetesfromcommonmolecularbackgroundtoviciouscircleofmetabolicsyndromecasereportandreviewofliterature
AT filipbossowski psoriasisinobeseadolescentswithdiabetesfromcommonmolecularbackgroundtoviciouscircleofmetabolicsyndromecasereportandreviewofliterature
AT magdalenaskorupska psoriasisinobeseadolescentswithdiabetesfromcommonmolecularbackgroundtoviciouscircleofmetabolicsyndromecasereportandreviewofliterature
AT hannamysliwiec psoriasisinobeseadolescentswithdiabetesfromcommonmolecularbackgroundtoviciouscircleofmetabolicsyndromecasereportandreviewofliterature
AT arturtadeuszbossowski psoriasisinobeseadolescentswithdiabetesfromcommonmolecularbackgroundtoviciouscircleofmetabolicsyndromecasereportandreviewofliterature
AT iwonaflisiak psoriasisinobeseadolescentswithdiabetesfromcommonmolecularbackgroundtoviciouscircleofmetabolicsyndromecasereportandreviewofliterature